1618 related articles for article (PubMed ID: 32962615)
21. Recent progress in targeted delivery vectors based on biomimetic nanoparticles.
Chen L; Hong W; Ren W; Xu T; Qian Z; He Z
Signal Transduct Target Ther; 2021 Jun; 6(1):225. PubMed ID: 34099630
[TBL] [Abstract][Full Text] [Related]
22. Heterologous and cross-species tropism of cancer-derived extracellular vesicles.
Garofalo M; Villa A; Crescenti D; Marzagalli M; Kuryk L; Limonta P; Mazzaferro V; Ciana P
Theranostics; 2019; 9(19):5681-5693. PubMed ID: 31534511
[TBL] [Abstract][Full Text] [Related]
23. Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation.
Garofalo M; Villa A; Brunialti E; Crescenti D; Dell'Omo G; Kuryk L; Vingiani A; Mazzaferro V; Ciana P
Nanotheranostics; 2021; 5(1):1-7. PubMed ID: 33391971
[TBL] [Abstract][Full Text] [Related]
24. Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification.
Liu Q; Li D; Pan X; Liang Y
J Nanobiotechnology; 2023 Sep; 21(1):334. PubMed ID: 37717008
[TBL] [Abstract][Full Text] [Related]
25. Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment.
Srivastava A; Rathore S; Munshi A; Ramesh R
Semin Cancer Biol; 2022 Nov; 86(Pt 1):80-100. PubMed ID: 35192929
[TBL] [Abstract][Full Text] [Related]
26. Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity.
Gudbergsson JM; Jønsson K; Simonsen JB; Johnsen KB
J Control Release; 2019 Jul; 306():108-120. PubMed ID: 31175896
[TBL] [Abstract][Full Text] [Related]
27. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
[TBL] [Abstract][Full Text] [Related]
28. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
Meng W; He C; Hao Y; Wang L; Li L; Zhu G
Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
[TBL] [Abstract][Full Text] [Related]
29. Engineering Extracellular Vesicles as Delivery Systems in Therapeutic Applications.
Wang L; Wang D; Ye Z; Xu J
Adv Sci (Weinh); 2023 Jun; 10(17):e2300552. PubMed ID: 37080941
[TBL] [Abstract][Full Text] [Related]
30. Extracellular vesicles as novel drug delivery systems to target cancer and other diseases: Recent advancements and future perspectives.
Ramesh D; Bakkannavar S; Bhat VR; Sharan K
F1000Res; 2023; 12():329. PubMed ID: 37868300
[TBL] [Abstract][Full Text] [Related]
31. Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery.
Geng T; Pan P; Leung E; Chen Q; Chamley L; Wu Z
Pharm Res; 2021 Feb; 38(2):179-197. PubMed ID: 33604783
[TBL] [Abstract][Full Text] [Related]
32. Engineered extracellular vesicles and their mimetics for clinical translation.
Kim H; Kim D; Nam H; Moon S; Kwon YJ; Lee JB
Methods; 2020 May; 177():80-94. PubMed ID: 31626895
[TBL] [Abstract][Full Text] [Related]
33. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
[TBL] [Abstract][Full Text] [Related]
34. Extracellular Vesicles in Modifying the Effects of Ionizing Radiation.
Szatmári T; Hargitai R; Sáfrány G; Lumniczky K
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698689
[TBL] [Abstract][Full Text] [Related]
35. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?
Muhammad SA
Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233
[TBL] [Abstract][Full Text] [Related]
36. Extracellular Vesicles in the Development of Cancer Therapeutics.
Sun H; Burrola S; Wu J; Ding WQ
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847103
[TBL] [Abstract][Full Text] [Related]
37. Engineered extracellular vesicles: A new approach for targeted therapy of tumors and overcoming drug resistance.
Ming-Kun C; Zi-Xian C; Mao-Ping C; Hong C; Zhuang-Fei C; Shan-Chao Z
Cancer Commun (Lond); 2024 Feb; 44(2):205-225. PubMed ID: 38155418
[TBL] [Abstract][Full Text] [Related]
38. Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design.
Kooijmans SAA; de Jong OG; Schiffelers RM
Adv Drug Deliv Rev; 2021 Jun; 173():252-278. PubMed ID: 33798644
[TBL] [Abstract][Full Text] [Related]
39. Gold nanoparticle based double-labeling of melanoma extracellular vesicles to determine the specificity of uptake by cells and preferential accumulation in small metastatic lung tumors.
Lara P; Palma-Florez S; Salas-Huenuleo E; Polakovicova I; Guerrero S; Lobos-Gonzalez L; Campos A; Muñoz L; Jorquera-Cordero C; Varas-Godoy M; Cancino J; Arias E; Villegas J; Cruz LJ; Albericio F; Araya E; Corvalan AH; Quest AFG; Kogan MJ
J Nanobiotechnology; 2020 Jan; 18(1):20. PubMed ID: 31973696
[TBL] [Abstract][Full Text] [Related]
40. M1-derived extracellular vesicles enhance photodynamic therapy and promote immunological memory in preclinical models of colon cancer.
Huis In 't Veld RV; Lara P; Jager MJ; Koning RI; Ossendorp F; Cruz LJ
J Nanobiotechnology; 2022 Jun; 20(1):252. PubMed ID: 35658868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
